North America’s BEST Small Cap Stock Ideas
Hemispherx Biopharma (HEB – $2.03) announced on Wednesday it cancelled its adjourned stockholders’ meeting. The reason was very simple, the Company obtained insufficient votes to pass proposal no. 3. With this proposal being the sole purpose of the adjourned stockholders’ meeting, there was no need to hold the meeting. In proposal 3, shareholders were asked if HEB could increase the […]
Read moreAlthough Acme United’s sales and earnings were impacted by the economic downturn in the second quarter, it’s encouraging to note that while net sales in the U.S. segment decreased 17% compared to the same period in 2008, sales in Canada only declined approximately 1% in local currency (down 12% in U.S. dollars) and even increased 11% in Europe in local […]
Read moreMany thanks to everybody who responded by e-mail or on our blog to last week’s appeal: “Do you have an idea why Orsus Xelent (ORS – $0.72) is trading at such a low P/E?”. Most answers were unanimous and something like: management (CEO, CFO and several members of the board) and the Company’s auditor has changed during the last few […]
Read moreOnce again Orsus Xelent (ORS – $0.75) reported excellent results. The Chinese designer and manufacturer of mobile phones for the Asian market announced revenues in the second quarter ended June 30, 2009 of $23,332,000, compared with $28,894,000 in the second quarter of 2008, a decline of 19.25%. However, net income increased 53.19% to $2,307,000 or $0.08 per share, up from […]
Read moreWhile we’re still waiting for the FDA to make a decision regarding Hemisperx Biopharma’s (HEB – $2.00) NDA for Ampligen to treat Chronic Fatigue Syndrome (CFS), mutual funds have been big buyers of HEB’s shares. In the second quarter, ending June 30, 2009, mutual funds have added 8.36 million shares of Hemispherx, or 6.6% of total shares outstanding, to their […]
Read moreAt a time of year when the number of press releases is relatively low, one Company, that we have been following for some time, stood out this week with two announcements: Clearfield Inc. (CLFD – $1.77) . Clearfield, which manufactures and sells fiber distribution systems, optical components, outside plant cabinets, and fiber and copper cable assemblies for the telecommunications industry, […]
Read more
With the second quarter a few days behind us, it’s time to find out how some of the companies that we track performed. With us to discuss the second quarter and many more interesting items that happened since our previous interview is Mr. Walter Johnsen, Exec. Chairman and CEO of Acme United Corp. (ACU – $9.00). Click the start button […]
Read moreNext to Hemispherx Biopharma Inc. (+ 572% since our recommendation) and Orsus Xelent Inc (+ 65% since our recommendation), we have a few more aces up our sleeve. Take, for instance, Global Green Solutions Inc. (GGRN – $0.12) , which we first recommended at $0.06 a few months ago, is making progress in both its business units: Greensteam, a commercial […]
Read moreOur guest today is Mr. Karl Puehringer, President and CEO of Baldwin Technology Co. Inc. (BLD – $0.91). Baldwin Technology Company, Inc., together with its subsidiaries, engages primarily in the development, manufacture, and sale of process automation equipment for the printing and publishing industry. Mr. Puehringer discusses the Company and the markets it operates in. Click the start button underneath […]
Read moreA few weeks ago, we wrote Hemispherx Biopharma’s (HEB – $2.73) shares were on a rollercoaster and it seems the ride is getting wilder and wilder. Obviously, there’s a tremendous amount of speculation about the FDA’s decision to approve Ampligen for Chronic Fatigue Syndrome (CFS). Based on all the public information out there, you have to form an opinion, and […]
Read more